000 01432 a2200445 4500
005 20250517102239.0
264 0 _c20190705
008 201907s 0 0 eng d
022 _a1778-7254
024 7 _a10.1016/j.jbspin.2016.04.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartis, Nihal
245 0 0 _aTocilizumab-induced hypofibrinogenemia: A report of 7 cases.
_h[electronic resource]
260 _bJoint bone spine
_c05 2017
300 _a369-370 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdult
650 0 4 _aAfibrinogenemia
_xchemically induced
650 0 4 _aAge Distribution
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFibrinogen
_xanalysis
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aInfusions, Intravenous
650 0 4 _aMiddle Aged
650 0 4 _aRisk Assessment
650 0 4 _aSampling Studies
700 1 _aChirio, David
700 1 _aQueyrel-Moranne, Viviane
700 1 _aZenut, Marie-Christine
700 1 _aRocher, Fanny
700 1 _aFuzibet, Jean-Gabriel
773 0 _tJoint bone spine
_gvol. 84
_gno. 3
_gp. 369-370
856 4 0 _uhttps://doi.org/10.1016/j.jbspin.2016.04.008
_zAvailable from publisher's website
999 _c26144387
_d26144387